دورية أكاديمية
أعرض في EDS

Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco.

التفاصيل البيبلوغرافية
العنوان: Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco.
المؤلفون: Lmimouni BE; Parasitology and Medical Mycology Laboratory, Military Hospital Teaching Mohammed the Fifth, BioInova Research Center, Faculty of Medicine and Pharmacy, University Mohammed the Fifth, Rabat 10100, Morocco., Hennequin C; Service de Parasitologie-Mycologie, Hôpital Saint-Antoine, AP-HP, 75012 Paris, France.; Centre de Recherche Saint-Antoine, CRSA, Inserm, Sorbonne Université, 75012 Paris, France., Penney ROS; Global Action for Fungal Infections, 1208 Geneva, Switzerland., Denning DW; Global Action for Fungal Infections, 1208 Geneva, Switzerland.; Manchester Academic Health Science Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
المصدر: Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2022 Apr 17; Vol. 8 (4). Date of Electronic Publication: 2022 Apr 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101671827 Publication Model: Electronic Cited Medium: Internet ISSN: 2309-608X (Electronic) Linking ISSN: 2309608X NLM ISO Abbreviation: J Fungi (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2015]-
مستخلص: Few data are published from Morocco on fungal disease, although numerous case reports attest to a wide range of conditions in the country. Here, we estimate for the first time the incidence and prevalence of serious fungal diseases in the country. Detailed literature searches in English and French were conducted for all serious fungal infections. Demographic and individual underlying condition prevalence or annual incidence were obtained from UNAIDS (HIV), WHO (TB) and other international sources. Deterministic modelling was then applied to estimate fungal disease burden. Morocco's population in 2021 was 36,561,800. Multiple publications describe various fungal diseases, but epidemiological studies are rare. The most frequent serious fungal infections were tinea capitis (7258/100,000) and recurrent vulvovaginal candidiasis (2794/100,000 females). Chronic pulmonary aspergillosis is also common at a prevalence of 19,290 (53/100,000) because of the relatively high rate of tuberculosis. The prevalence of asthma in adults exceeds one million, of whom fungal asthma (including allergic bronchopulmonary aspergillosis (ABPA)) probably affects 42,150 (115/100,000). Data are scant on candidaemia (estimated at 5/100,000), invasive aspergillosis (estimated at 4.1/100,000), HIV-related complications such as cryptococcal meningitis and Pneumocystis pneumonia and mucormycosis. Fungal keratitis is estimated at 14/100,000). Mycetoma and chromoblastomycosis are probably rare. Fungal disease is probably common in Morocco and diagnostic capacity is good in the teaching hospitals. These estimates need confirmation with methodologically robust epidemiological studies.
References: Ann Phys Rehabil Med. 2010 Dec;53(10):650-4. (PMID: 21126936)
Asian Cardiovasc Thorac Ann. 2019 Jul;27(6):476-480. (PMID: 31166694)
Curr Opin Crit Care. 2010 Oct;16(5):445-52. (PMID: 20711075)
Diagn Microbiol Infect Dis. 2020 Nov;98(3):115124. (PMID: 32736160)
Respir Med. 2012 Dec;106 Suppl 2:S25-32. (PMID: 23290701)
J Mycol Med. 2011 Mar;21(1):51-4. (PMID: 24451504)
BMC Surg. 2015 Oct 16;15:114. (PMID: 26475478)
Allergy Rhinol (Providence). 2021 Aug 23;12:21526567211036146. (PMID: 34457373)
Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1056-1061. (PMID: 28826456)
Health Aff (Millwood). 2007 Jul-Aug;26(4):1009-16. (PMID: 17630444)
Respir Med. 2001 May;95(5):341-7. (PMID: 11392574)
Pan Afr Med J. 2018 Jun 14;30:131. (PMID: 30374377)
Sante Publique. 2014 Mar-Apr;26(2):199-204. (PMID: 25108961)
J Mycol Med. 2015 Mar;25(1):76-80. (PMID: 25649200)
Eur Respir J. 2019 Mar 18;53(3):. (PMID: 30705126)
AIDS Res Ther. 2012 Feb 14;9(1):5. (PMID: 22333070)
Eur Respir J. 2021 Aug 19;58(2):. (PMID: 33479108)
Pathol Biol (Paris). 2013 Jun;61(3):108-12. (PMID: 22542426)
Asian Cardiovasc Thorac Ann. 2020 Jan;28(1):33-38. (PMID: 31799858)
PLoS Negl Trop Dis. 2020 Sep 24;14(9):e0008397. (PMID: 32970667)
Chirurgie. 1999 Dec;124(6):655-60. (PMID: 10676027)
J Mycol Med. 2011 Sep;21(3):206-9. (PMID: 24451564)
J Mycol Med. 2012 Jun;22(2):185-8. (PMID: 23518022)
Tunis Med. 2002 Jan;80(1):29-32. (PMID: 12071041)
J Mycol Med. 2011 Mar;21(1):1-5. (PMID: 24451494)
East Mediterr Health J. 2020 Aug 25;26(8):957-966. (PMID: 32896891)
Isr Med Assoc J. 2015 Jun;17(6):374-9. (PMID: 26233998)
Bull World Health Organ. 2011 Dec 1;89(12):864-72. (PMID: 22271943)
J Mycol Med. 2016 Mar;26(1):e1-5. (PMID: 26778722)
BMC Clin Pathol. 2017 Feb 2;17:1. (PMID: 28167862)
J Infect Public Health. 2020 Dec;13(12):2080-2086. (PMID: 31248814)
Med Mycol. 2019 Apr 1;57(Supplement_2):S94-S103. (PMID: 30816963)
Cancer. 2009 Nov 1;115(21):5018-25. (PMID: 19637340)
Clin Microbiol Infect. 2011 Dec;17(12):1882-9. (PMID: 21668573)
Thorax. 2022 Aug;77(8):821-828. (PMID: 34848556)
Med Mal Infect. 2015 Apr;45(4):128-32. (PMID: 25703538)
Maroc Med. 1974 Nov;54(584):612-30. (PMID: 4456054)
PLoS Negl Trop Dis. 2021 Aug 12;15(8):e0009611. (PMID: 34383752)
J Mycol Med. 2016 Dec;26(4):331-336. (PMID: 27520534)
BMC Pulm Med. 2020 Sep 11;20(1):241. (PMID: 32912168)
Bull Soc Pathol Exot. 2018;111(1):24-30. (PMID: 30763499)
Ann Biol Clin (Paris). 2008 Jan-Feb;66(1):79-81. (PMID: 18227007)
Med Trop (Mars). 2003;63(2):171-4. (PMID: 12910657)
J Clin Neurosci. 2009 Jun;16(6):840-1. (PMID: 19297169)
Lancet Infect Dis. 2018 Nov;18(11):e339-e347. (PMID: 30078662)
Respir Med. 2009 Dec;103 Suppl 2:S2-11. (PMID: 20122625)
Clin Infect Dis. 2012 Nov 15;55(10):1352-61. (PMID: 22893576)
Bull Soc Pathol Exot. 2013 Feb;106(1):9-12. (PMID: 23385788)
Pan Afr Med J. 2014 Mar 27;17:229. (PMID: 25170373)
Presse Med. 2012 Jul;41(7-8):e386-90. (PMID: 22350063)
Pan Afr Med J. 2019 Jul 23;33:249. (PMID: 31692764)
Rev Pneumol Clin. 2010 Dec;66(6):342-6. (PMID: 21167441)
Mycoses. 2021 Oct;64(10):1203-1212. (PMID: 33971053)
Respir Med. 2012 May;106(5):724-9. (PMID: 22349065)
Eur Respir J. 2011 Apr;37(4):865-72. (PMID: 20595150)
Med Mal Infect. 2011 Mar;41(3):163-4. (PMID: 21194861)
Clin Transl Allergy. 2014 Apr 15;4:14. (PMID: 24735832)
Clin Microbiol Infect. 2011 Jul;17(7):1061-7. (PMID: 20825438)
Lancet Infect Dis. 2017 Aug;17(8):873-881. (PMID: 28483415)
J Med Case Rep. 2018 Dec 28;12(1):383. (PMID: 30591075)
J Mycol Med. 2012 Sep;22(3):261-4. (PMID: 23518085)
Respir Med. 2012 Dec;106 Suppl 2:S75-85. (PMID: 23290706)
Med Mal Infect. 2012 Apr;42(4):171-3. (PMID: 22465059)
Int J Surg Case Rep. 2021 May;82:105882. (PMID: 33865198)
Cancer Radiother. 2009 Jul;13(4):337-9. (PMID: 19524468)
Pan Afr Med J. 2013;14:24. (PMID: 23504196)
Clin Microbiol Infect. 2010 Jul;16(7):870-7. (PMID: 19906275)
J Fungi (Basel). 2017 Oct 18;3(4):. (PMID: 29371573)
Int J Surg Case Rep. 2016;24:97-100. (PMID: 27227446)
فهرسة مساهمة: Keywords: Aspergillus; Candida; Cryptococcus; Pneumocystis; keratitis
تواريخ الأحداث: Date Created: 20220421 Latest Revision: 20230916
رمز التحديث: 20230916
مُعرف محوري في PubMed: PMC9025078
DOI: 10.3390/jof8040414
PMID: 35448645
قاعدة البيانات: MEDLINE
الوصف
تدمد:2309-608X
DOI:10.3390/jof8040414